IHS Chemical Week

Regions :: Western Europe

DSM reports lower sales, earnings on negative currency effects, weakness in caprolactam

12:35 AM MDT | August 5, 2014 | Natasha Alperowicz

DSM today reported second-quarter net profit from continuing operations before exceptional items of €110 million ($147.6 million), 20% down on the year-earlier quarter. Revenues from continuing operations were flat, €2.29 billion, and Ebitda was 12% lower, €293 million. The nutrition segment's revenues dropped 3%, to €1.07 billion, and Ebitda was 11% down, at €222 million. The performance materials business recorded sales of €702 million, 1% down on the second quarter of 2013, and a 10% rise in Ebitda, to €88 million. Polymer...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa